title: Triiodothyronine rapidly lowers plasma lipoprotein (a) in hypothyroid subjects.
abstract: BACKGROUND
  Increases in plasma low-density-lipoprotein (LDL) cholesterol and apolipoprotein B (apo-B) are well known in primary hypothyroidism, but it is uncertain whether thyroid dysfunction is associated with elevated levels of the atherogenic lipoprotein (a) (Lp(a)).
  
  
  METHODS
  The effect of short-term hypothyroidism on plasma Lp(a) was studied in 14 patients who had undergone a total thyroidectomy because of a well-differentiated thyroid carcinoma. They were studied 2 weeks after withdrawal of triiodothyronine (T3) therapy and 7 (5-9) weeks after resumption of T3 treatment (75-100 micrograms T3 daily). Fourteen euthyroid subjects served as controls.
  
  
  RESULTS
  In the hypothyroid phase the athyreotic patients had higher levels of Lp(a) (105 [12-536] vs. 42 [1-321] mg/l, p < 0.05), apo-B (p < 0.001) and LDL cholesterol (p < 0.001) as compared with the euthyroid control subjects. T3 therapy lowered Lp(a) by 29% to 50 (12-535) mg/l, p < 0.01. Apo B and LDL cholesterol fell by 42% (p < 0.001) and by 53% (p < 0.001), respectively. After resumption of T3 therapy the levels of Lp(a), apo-B and LDL cholesterol were not different from those of the control subjects. The mean percentual decreases in Lp(a) and in apo-B were similar, although the individual changes in Lp(a) were more variable.
  
  
  CONCLUSIONS
  Short-term hypothyroidism increases plasma Lp(a) and T3 therapy rapidly lowers Lp(a) together with apo-B and LDL cholesterol. Our findings support the hypothesis that thyroid hormone regulates plasma Lp(a) and apo-B in a parallel manner. Elevated concentrations of Lp(a) in combination with LDL cholesterol may be involved in the increased risk of cardiovascular disease assumed to be associated with hypothyroidism.
authors.affiliation: Department of Endocrinology, University Hospital, Groningen, Netherlands.
authors.forename: R P
authors.initials: RP
authors.lastname: Dullaart
authors.forename: J J
authors.initials: JJ
authors.lastname: van Doormaal
authors.forename: K
authors.initials: K
authors.lastname: Hoogenberg
authors.forename: W J
authors.initials: WJ
authors.lastname: Sluiter
mesh_terms: D000328:Adult; D001055:Apolipoproteins B / Q000187:drug effects; D008078:Cholesterol, LDL / Q000187:drug effects; D005260:Female; D006801:Humans; D007037:Hypothyroidism / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D017270:Lipoprotein(a) / Q000097:blood / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D013965:Thyroidectomy / Q000009:adverse effects; D014284:Triiodothyronine / Q000494:pharmacology*
chemical_list: D001055:Apolipoproteins B; D008078:Cholesterol, LDL; D017270:Lipoprotein(a); D014284:Triiodothyronine